Filing Impact
Filing Sentiment
Form Type
4
Fennec Pharmaceuticals Inc
Aug 5, 2025
[144] Fennec Pharmaceuticals Inc. SEC Filing
225.37M
22.75M
16.26%
57.78%
4.72%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
RESEARCH TRIANGLE PARK